Polyethylene Glycol 4000 Storage — PEG 4000 / Macrogol 4000 Pharmaceutical Excipient Tank Selection

Polyethylene Glycol 4000 Storage — PEG 4000 / Macrogol 4000 Pharmaceutical Excipient Tank, Hopper, and Melt-Reservoir Selection for Suppositories, Hot-Melt Extrusion, and Tablet Manufacture

Polyethylene glycol 4000 (PEG 4000, Macrogol 4000, CAS 25322-68-3 generic family designation) is the dominant solid-grade polyethylene glycol in pharmaceutical formulation. The polymer is a condensation product of ethylene oxide with a nominal weight-average molecular weight of 3,500-4,500 g/mol, supplied as flake, powder, or prill in 25 kg drums, supersacks, and bulk railcars. At room temperature the material is a waxy white solid; at 55-60 C it melts to a clear viscous liquid; at 80-100 C it becomes a low-viscosity pumpable melt. The pharmaceutical applications span suppository / pessary base (PEG 4000 + PEG 400 binary blend at 80:20 to 60:40 weight ratio gives the standard glycerogelatin-alternative base), hot-melt extrusion (HME) carrier polymer for amorphous solid dispersions, PEGylation precursor for protein and peptide drug conjugation, lubricant and plasticizer for tablet and capsule manufacture, and the bulk laxative active in osmotic-laxative products (the US OTC Miralax and prescription GoLytely use PEG-3350, a slightly lower MW grade nominally interchangeable with Macrogol 4000 for the laxative indication; the EU Movicol product uses Macrogol 4000 directly).

This pillar covers the bulk-bag receiving, silo / drum / IBC storage, melt-reservoir tank, and dispensary considerations for PEG 4000 at the pharmaceutical formulator scale — everything from a 25 kg drum of Carbowax Sentry PEG 4000 NF in a suppository R&D lab through a 50,000 lb bulk railcar delivery to an osmotic-laxative manufacturer feeding 5,000 gallon heat-traced melt tanks. Citations are to Dow (Carbowax and Carbowax Sentry brands, manufactured at Plaquemine LA, Texas City TX, and global plants), BASF Pharma Solutions (Pluracare and Lutrol brands, manufactured at Geismar LA and Ludwigshafen DE), Clariant (Polyglykol brand, manufactured in Germany), and Sasol Performance Chemicals (Marlosolan / Sasolwax brand, manufactured in South Africa and the US). Regulatory citations: USP-NF Polyethylene Glycol monograph (Pharmacopeial Discussion Group harmonized), Ph.Eur. Macrogols, JP Polyethylene Glycol, FDA Inactive Ingredient Database, 21 CFR 211 cGMP, ICH Q3D Guideline for Elemental Impurities (R2), and 21 CFR 184.1330 (PEG 200-9500 GRAS for food applications).

1. Material Compatibility Matrix

PEG 4000 in solid form is chemically inert. PEG 4000 melt at 60-100 C is a mildly hot organic liquid with no aggressive chemical reactivity but with elevated thermal-stress and oxidative-degradation potential at the higher end of the melt-temperature range. Material selection follows pharma cGMP standards plus heat-tracing and oxidation-control requirements for melt-reservoir applications.

Practical melt-reservoir tank construction: 316L jacketed body for steam, hot-water, or thermal-fluid heat-tracing to 80-100 C operating temperature, top-mounted slow-speed agitator (avoid high shear which can mechanically degrade PEG molecular weight), top inlet with sifting screen at the powder / flake / prill charge port, level instrumentation, and bottom discharge with PTFE-lined or Viton-seated valve. Inert-gas (nitrogen) blanketing is highly recommended for melt-reservoir tanks running long-cycle continuous service — PEG molten in air slowly oxidizes to formaldehyde, formic acid, and lower-MW peroxide species that contaminate the product. The 21 CFR 211.94 container-closure provision applies to melt-tank inerting design.

2. Real-World Pharmaceutical Use Cases

Suppository and Pessary Base (PEG 4000 + PEG 400 Binary Blend). The dominant pharmaceutical use of PEG 4000 is as the solid component of a binary suppository base — typical formulation 80:20 PEG 4000 : PEG 400 by weight, melted at 60-65 C, blended with API and excipients, and cast into suppository molds. The resulting suppositories soften and dissolve at body temperature in the rectal or vaginal cavity, releasing the API. The PEG-base suppository system replaces the older glycerogelatin and cocoa-butter bases and is the global standard for modern suppository manufacture. Plant-scale inventory at a suppository CMO typically runs 50,000-200,000 lb of PEG 4000 in dedicated melt tanks plus drum / supersack reserves.

Hot-Melt Extrusion (HME) Carrier Polymer. PEG 4000 is one of the standard carrier polymers for hot-melt-extrusion amorphous solid dispersions of poorly-soluble APIs. The drug + PEG melt is extruded at 80-130 C through a co-rotating twin-screw extruder, cooled to glassy / waxy solid, and milled to powder for capsule fill or tablet compression. The amorphous-dispersion format dramatically improves dissolution rate and bioavailability for BCS Class II and IV drugs. HME plant-scale operations consume 1,000-10,000 lb of PEG 4000 per week with melt-reservoir tanks feeding the extruder hopper.

Osmotic Laxative Active (PEG-3350 / Macrogol 4000). The Miralax (Bayer / Bausch Health), GoLytely (Braintree Laboratories), and Movicol (Norgine) products are osmotic-laxative formulations where PEG 4000 (or the slightly lower-MW PEG-3350 in US labeling) is the active ingredient at 17-100 g daily oral dose. The PEG retains water in the colon by osmosis without absorption, softening stool for elimination. These products consume PEG 4000 / 3350 at multi-thousand-tonne annual volume in dedicated bulk-handling facilities.

Tablet and Capsule Lubricant / Plasticizer. PEG 4000 at 1-5% in tablet formulations functions as a secondary lubricant alongside magnesium stearate, with the additional benefit of plasticizing film coatings to reduce coating brittleness. PEG 4000 + PEG 400 blends are also used as plasticizer in ethyl-cellulose and shellac coatings.

PEGylation Precursor. PEG 4000 hydroxyl-terminated and methoxy-terminated grades (mPEG 4000) are starting materials for derivatization to PEG-NHS, PEG-maleimide, and PEG-aldehyde reagents used in protein and peptide PEGylation. The PEGylation reaction conjugates the polymer to a therapeutic protein to extend circulation half-life, reduce immunogenicity, and improve solubility. Marketed PEGylated drugs include peg-interferon products, peg-asparaginase, and peg-filgrastim. The PEG 4000 starting material is supplied at higher purity grade (low-polydispersity, low-aldehyde-content) than standard pharmaceutical PEG 4000 for this application.

Topical Ointment Base (PEG Ointment NF). The PEG Ointment NF monograph specifies a 60:40 blend of PEG 3350 (PEG 4000 nominal) and PEG 400 as a water-soluble ointment base for dermal API delivery. The base is preferred over petrolatum-based ointments when water-washability and non-greasy feel are required.

3. Regulatory and Pharmacopoeial Compliance

USP-NF Monograph Requirements. The Polyethylene Glycol monograph (PDG-harmonized) covers the full PEG molecular-weight series from PEG 200 through PEG 8000 with grade-specific viscosity, hydroxyl number, freezing/melting range, pH, water content, and ethylene oxide / 1,4-dioxane residual-monomer specifications. For PEG 4000 specifically: average molecular weight 3,000-4,800 g/mol (the wide window reflects historic differences between USP, Ph.Eur., and JP — modern PDG-harmonized text has narrower 3,500-4,500 g/mol range for specific grade), congealing range 50-58 C, viscosity at 20 C as 5% aqueous solution 6.4-7.8 mm2/s, hydroxyl number 25-32 mg KOH/g, ethylene oxide residual not more than 1 ppm, 1,4-dioxane residual not more than 10 ppm, and microbial enumeration per USP <61> / <62>. The ethylene oxide and 1,4-dioxane limits are critical — both are residual monomers / by-products from the synthesis and both are ICH M7 mutagenic-impurity concerns.

FDA Inactive Ingredient Database. PEG 4000 (variously listed as PEG 3350, polyethylene glycol 4000, macrogol 4000) is one of the most extensively listed pharmaceutical excipients in the IID, with maximum-daily-exposure precedent for oral, rectal, vaginal, topical, and parenteral routes spanning multi-gram daily doses (the laxative indication) down to milligram-level use. The IID listing is the primary regulatory justification for PEG 4000 selection in new formulations.

ICH Q3D (R2) Elemental Impurities. PEG 4000 is a synthetic polymer with low intrinsic heavy-metal content. The ICH Q3D Class 1 elements (Cd, Pb, As, Hg) are typically <1 ppm in commercial pharma-grade PEG 4000; Class 2 and 3 elements are below their respective component-approach PDE thresholds. Procurement files for cGMP PEG 4000 purchases should include the supplier elemental-impurity certificate of analysis as a routine line item.

21 CFR 184.1330 GRAS for Food Applications. The same PEG 4000 polymer used in pharmaceutical applications has GRAS status under 21 CFR 184.1330 for use as direct food additive (coatings on dietary supplements and food ingredients) at limited use levels. Pharma-grade PEG 4000 (Carbowax Sentry NF, BASF Pluracare, etc.) is produced on dedicated lines with full cGMP compliance, distinct from the industrial-grade Carbowax used in textile sizing, paper coating, and lubricant applications.

21 CFR 211 cGMP for Finished Pharmaceuticals. PEG 4000 handling falls under 21 CFR 211.80-211.87 component-handling provisions. For melt-reservoir operations: 21 CFR 211.65 (equipment construction) and 21 CFR 211.67 (equipment cleaning and maintenance) apply specifically to the heat-traced melt tanks — cleaning validation must demonstrate removal of cross-product residue from the melt tank between products, with attention to any melt-degradation polymer that adheres to vessel walls.

OSHA HazCom and Thermal Hazards. PEG 4000 solid is non-hazardous in the OSHA sense (no GHS health classifications; respirable-dust PEL 5 mg/m3 as PNOR). PEG 4000 melt at 60-100 C presents thermal-burn hazards; PPE includes heat-resistant gloves, face shield, and apron at the melt-tank charge port and at melt-transfer connections.

4. Storage System Specification

Solid-Form Bulk Storage. High-volume osmotic-laxative manufacturers receiving PEG 4000 by bulk railcar (50,000 lb load) discharge through a pneumatic-conveyor or screw-conveyor transfer to dedicated 316L stainless silos at 30,000-100,000 lb capacity. The configuration follows MCC silo standards: 316L body, mass-flow cone, electropolished interior, dust-cartridge filter, level instrumentation, full-port butterfly discharge. Mid-volume operations stage PEG 4000 in 1,000-2,500 lb supersacks on pallet rack; lab and small-production operations stage 25 kg drums.

Melt-Reservoir Tank. The dominant storage configuration for high-throughput suppository and HME operations is the heat-traced melt-reservoir tank. Critical features: 316L jacketed body sized 200-5,000 gallons, jacket fed with 90-100 C steam or hot water (or thermal fluid for higher-temperature HME applications), top-mounted slow-speed paddle or anchor agitator, top charge port with sifting screen for solid-form addition, top vent with HEPA filter or nitrogen blanket connection, level instrumentation (radar or guided-wave), bottom discharge with PTFE-lined ball valve or Viton-seated butterfly valve, and high-temperature insulation cladding for personnel-protection and energy-efficiency. Inert-gas blanketing with low-flow nitrogen at 1-3 scfh per 1,000 gallons of headspace prevents oxidative degradation in long-cycle continuous service.

Heat Tracing for Transfer Lines. PEG 4000 melt transfer between reservoir and use point requires heat-traced piping at 70-90 C to maintain pumpability. Standard configuration: 316L stainless tubing with electric heat-tracing cable (self-regulating to 100-130 C maximum) and high-temperature fiberglass or rockwool insulation. Trace-end controls at the use point (pump intake, extruder hopper, suppository-mold filling head) are critical to avoid solidified-melt blockage at the dead-zone transition.

Pump Selection for Melt Service. Gear pumps (Viking, Maag) or progressive-cavity pumps (Moyno) with 316L wetted parts and Viton or PTFE seals are standard for PEG 4000 melt transfer. Centrifugal pumps are NOT used — the high viscosity (200-300 cP at 80 C) is outside centrifugal-pump efficiency window. Heat-traced pump body and discharge piping match the transfer-line configuration.

Drum / Supersack Melt-Out Stations. Plants without bulk railcar capability use drum or supersack melt-out stations — insulated cabinet enclosures with electric heaters that bring drum or supersack contents to 70-80 C over 8-24 hours, then transfer the molten PEG to a melt reservoir or use-point tank. Drum melt-out cabinets are commercially available from Drum Heater Corp, Powerblanket, and similar suppliers.

5. Field Handling Reality

Solidification on Dead Zones is the Dominant Operational Risk. PEG 4000 melt at 60-80 C will solidify in any cold spot in the transfer-line system — an unheated valve body, a poorly-insulated flange, a cold-end transition at the use point. Once solidified, the blockage requires careful re-melt or mechanical removal. Plant SOPs should emphasize complete heat-tracing coverage, redundant trace-circuit reliability, and end-of-shift / end-of-batch line drain-down to prevent stagnant-melt solidification. The most expensive failure mode is solidified PEG inside a metering pump that requires disassembly to clear — a well-designed system has heat-traced suction and discharge lines with steam-out or hot-water flush capability for emergency clearing.

Oxidative Degradation in Long-Cycle Melt Storage. PEG 4000 melt held at 80-100 C in air for extended periods (days to weeks) slowly oxidizes to formaldehyde, formic acid, and peroxide species. The degradation accelerates above 100 C and in the presence of metal-particulate contamination (iron, copper). The visible signs are color development from clear to yellow to amber and odor development from neutral to acrid. Quantitative monitoring is by hydroxyl number drift (drops below specification as ether-bond cleavage proceeds) and by formaldehyde / peroxide testing. Standard control is nitrogen blanketing on the melt tank, controlled hold time (no more than 7-14 days at melt without product turnover), and 316L-only product-contact metallurgy.

1,4-Dioxane Residual Drift. Modern pharma-grade PEG 4000 carries a 1,4-dioxane residual specification of 10 ppm or lower at release. The 1,4-dioxane is a synthesis by-product that can re-form slowly during high-temperature melt storage above 100 C. ICH M7 classifies 1,4-dioxane as Class 2 (known mutagen) with 380 microgram/day permitted daily exposure for adult oral pharmaceutical use. Plant SOPs for melt-reservoir operations should specify maximum melt temperature (typically 80-90 C, never above 100 C) and periodic 1,4-dioxane verification on melt-reservoir samples for products with high-PEG-content formulations.

Molecular Weight Drift on Mechanical Stress. High-shear mechanical stress on PEG 4000 melt — particularly in centrifugal pumps, high-shear mixers, or twin-screw extruders — can cause polymer-chain scission with measurable MW reduction. The standard control is gear-pump or progressive-cavity pump selection (low-shear), slow-speed paddle agitator on melt tanks (anchor or helical-ribbon, never high-shear rotor-stator), and validated extruder screw design for HME applications. Plant SOPs may include in-process MW verification on twin-screw extruder output for high-precision HME products.

Confusion Between PEG 3350 and PEG 4000. The US osmotic-laxative market labels the active as PEG 3350; the EU labels the same active as Macrogol 4000. The two are nominally interchangeable for the laxative indication and for many other pharma applications, but the formal MW specifications differ slightly: PEG 3350 USP is 3,000-3,700 g/mol average, PEG 4000 Ph.Eur. (Macrogol 4000) is 3,500-4,500 g/mol average. Cross-formulation switching between PEG 3350 and PEG 4000 in a marketed product requires regulatory variation. Plant procurement and formulation documentation must specify the exact USP/EP grade explicitly.

Related Chemistries in the Organic Acid Cluster

Related chemistries in the organic acid cluster (food + pharma + cleaning + preservative + biodegradable chelation + protein carboxylate + anionic / amphoteric / nonionic surfactant + hydrotrope + cellulose-derivative excipient + polysaccharide + sugar carbohydrate excipient chemistry):

• Povidone (PVP) — Hydrophilic polymer excipient companion chemistry
• Crospovidone (PVP-CL) — Polymer excipient companion chemistry
• HPMC (Hypromellose) — Hydrophilic polymer excipient companion chemistry
• Polyethylene Glycol (PEG) — PEG-family parent chemistry
• Propylene Glycol — Polyol companion chemistry

Related Hub Pillars

For broader chemistry context, see the OneSource Plastics high-traffic chemical-compatibility hub pillars:

• Sulfuric Acid (H₂SO₄)
• Sodium Hydroxide (NaOH / caustic soda)